Sara J. Hardy, M.D.

Awards

2018
Holman Research Pathway

2018
Roentgen Resident/Fellow Research Award
Sponsor: Radiological Society of North America

VIEW ALL expand_more

Clinical Trials

Early Telehealth Visits for Discussion of Advanced Directives for Patients Newly Diagnosed With High Grade Glioma: Impact on Patient Care and Satisfaction

Lead Researcher: Sara J Hardy

High grade gliomas (HGGs) are rapidly progressive brain tumors resulting in death for most patients between 6 months and 2 years after diagnosis. It is important for patients with HGG to discuss and document their wishes at the end of life. However, many of these patients experience early changes in cognition which impede their decision-making. For this reason, these patients should have early discussions with their providers. However, implementation of this remains challenging in clinical practice. In this study, we will create an Early STructured Advanced care Referrals by Telehealth (Early START) visit for patients soon after their initial oncology visit. A checklist and pre-visit guide were developed to help guide the visit for both the provider and patient. Providers will receive special training in running these visits. Caregivers and/or family members will be encouraged to participate. Visits will be done using video or telephone and recorded. For patients who do not have access to technology for these visits, it will be provided. After the visit, patients, caregivers and/or family who participated, and providers will fill out surveys to address feasibility of having these extra visits and improve the visits for future. Patients will be followed until death. Caregivers and/or family who participated will be asked about whether end of life was in line with the patient's wishes. We will also use the patient's medical record to assess other aspects of end of life. We will compare end of life outcomes with other similar patients treated at our center.

View Study Details

Publications

Journal Articles

2/4/2022
Belcher EK, Culakova E, Gilmore NJ, Hardy SJ, Kleckner AS, Kleckner IR, Lei L, Heckler C, Sohn MB, Thompson BD, Lotta LT, Werner ZA, Geer J, Hopkins JO, Corso SW, Rich DQ, van Wijngaarden E, Janelsins MC. "Inflammation, Attention, and Processing Speed in Patients with Breast Cancer before and after Chemotherapy." Journal of the National Cancer Institute.. 2022 Feb 4; Epub 2022 Feb 04.

2/25/2020
Milano MT, Bates JE, Budnik J, Qiu H, Hardy S, Cummings MA, Baumgart MA, Maggiore RJ, Mulford DA, Usuki KY. "Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis." Lung cancer management.. 2020 Feb 25; 9(1):LMT25. Epub 2020 Feb 25.

12/2019
Milano MT, Hardy SJ, Chowdhry AK. "Nivolumab without brain radiotherapy is insufficient for the treatment of most patients with brain metastases from clear cell renal cell carcinoma." Annals of translational medicine.. 2019 Dec; 7(Suppl 8):S366.

Books & Chapters

2018
Chapter Title: Hypopituitarism
Book Title: Adult CNS Radiation Oncology
Author List: Hardy S; Shafiq I; Milano M; Vates E; Constine L
Published By: Springer International Publishing AG 2018

VIEW ALL PUBLICATIONS